Clinical Trials Directory

Trials / Unknown

UnknownNCT03282253

Elevated Stearoyl-CoA Desaturase-1 Expression Predicts the Disease Severity of Severe Acute Pancreatitis

Elevated Stearoyl-CoA Desaturase-1 Expression Predicts the Disease Severity and Clinical Outcomes of Severe Acute Pancreatitis

Status
Unknown
Phase
Study type
Observational
Enrollment
216 (estimated)
Sponsor
Nanjing University School of Medicine · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

In this study, the investgatiors aimed to investigate the associations between serum levels of stearoyl-CoA desaturase-1(SCD-1) and the disease severity as well as the presence of adverse clinical events, such as local complications, organ failure, mortality and so on.In this prospective study, participants were divided into two groups based on serum SCD-1 concentration on admission and prospectively observe the disease severity and clinical outcomes of them.

Conditions

Timeline

Start date
2018-01-01
Primary completion
2018-12-30
Completion
2019-06-30
First posted
2017-09-13
Last updated
2017-11-27

Source: ClinicalTrials.gov record NCT03282253. Inclusion in this directory is not an endorsement.